3. Duplicative Therapy

FDA-approved enzyme replacement therapies are indicated for specific enzyme deficiencies. Patients with multiple enzyme deficiencies may be prescribed multiple enzyme replacement therapies concurrently. Adjunctive administration of enzyme replacement therapies without multiple enzyme deficiency diagnoses is not clinically reasonable and will be evaluated.